IFNA1 and COVID-19: However, at the same time it is known SARS-CoV-2–infected IFNAR1 KO mice, lacking IFN-α/β signalling, have reduced inflammation and lymphocyte activation, which would support the notion that IFN-α/β can drive pathogenic inflammation in COVID-19 (15).